Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease

被引:90
|
作者
Morrow, David A. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
angina; atherosclerosis; myocardial infarction; prevention; prognosis; C-REACTIVE PROTEIN; ELEVATION MYOCARDIAL-INFARCTION; BRAIN NATRIURETIC PEPTIDE; ASSOCIATION TASK-FORCE; 2002 GUIDELINE UPDATE; PROGNOSTIC VALUE; FOLLOW-UP; SCIENTIFIC STATEMENT; DIABETIC-PATIENTS; AMERICAN-COLLEGE;
D O I
10.1161/CIRCULATIONAHA.109.852749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Risk assessment is essential to effective medical decision making for secondary prevention. A variety of clinical tools, including the most basic elements of the clinical history and the physical examination, provide valuable information on prognosis. In addition, data from the ECG, laboratory testing, and noninvasive and invasive imaging are complementary with respect to prognosis and can aid in informing patients and their families, directing triage, and guiding medical therapy. An integrated approach to risk assessment is optimal, and simple clinical risk scores can assist the clinician in assimilating the diverse sources of data on prognosis. Emerging tools for risk assessment continue to provide new insights into the pathogenesis of atherothrombosis and may advance the extent to which the promise of personalized preventive medicine can be realized in our routine care of patients with CV disease. Although discussed in the context of CHD, these principles are important to the full spectrum of patients with peripheral and cerebrovascular atherosclerotic disease. © 2010 American Heart Association, Inc.
引用
收藏
页码:2681 / 2691
页数:11
相关论文
共 50 条
  • [31] Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul Study
    Ku, Ivy A.
    Farzaneh-Far, Ramin
    Vittinghoff, Eric
    Zhang, Mary H.
    Na, Beeya
    Whooley, Mary A.
    ATHEROSCLEROSIS, 2011, 217 (02) : 503 - 508
  • [32] Telomere length as a biomarker of the risk of cardiovascular complications in patients with coronary heart disease
    Doroshchuk, N. A.
    Lankin, V. Z.
    Tikhaze, A. K.
    Kheimets, G., I
    Smirnova, M. D.
    Chazova, I. E.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (01) : 20 - 24
  • [33] High-sensitivity cardiac troponin for risk prediction in patients with and without coronary heart disease
    Hochholzer, Willibald
    Valina, Christian M.
    Stratz, Christian
    Amann, Michael
    Schlittenhardt, Daniel
    Buettner, Heinz Joachim
    Trenk, Dietmar
    Neumann, Franz-Josef
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (02) : 444 - 449
  • [34] Association of Resistin With Heart Failure and Mortality in Patients With Stable Coronary Heart Disease: Data From the Heart and Soul Study
    Zhang, Mary H.
    Na, Beeya
    Schiller, Nelson B.
    Whooley, Mary A.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (01) : 24 - 30
  • [35] Thoracic Aortic Calcium Versus Coronary Artery Calcium for the Prediction of Coronary Heart Disease and Cardiovascular Disease Events
    Wong, Nathan D.
    Gransar, Heidi
    Shaw, Leslee
    Polk, Donna
    Moon, Johanna H.
    Miranda-Peats, Romalisa
    Hayes, Sean W.
    Thomson, Louise E. J.
    Rozanski, Alan
    Friedman, John D.
    Berman, Daniel S.
    JACC-CARDIOVASCULAR IMAGING, 2009, 2 (03) : 319 - 326
  • [36] A genetic risk score predicts cardiovascular events in patients with stable coronary artery disease
    Christiansen, Morten Krogh
    Nyegaard, Mette
    Larsen, Sanne Bojet
    Grove, Erik Lerkevang
    Wurtz, Morten
    Neergaard-Petersen, Sos
    Hvas, Anne-Mette
    Jensen, Henrik Kjaerulf
    Kristensen, Steen Dalby
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 241 : 411 - 416
  • [37] Future directions in cardiovascular disease risk prediction
    Doust, Jenny A.
    Bonner, Carissa
    Bell, Katy J. L.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2020, 49 (08) : 488 - 494
  • [38] Framing Cardiovascular Disease Event Risk Prediction
    Stone, James A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (02) : 171 - 173
  • [39] Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - Results from EUROPA
    van der Leeuw, Joep
    Oemrawsingh, Rohit M.
    van der Graaf, Yolanda
    Brugts, Jasper J.
    Deckers, Jaap W.
    Bertrand, Michel
    Fox, Kim
    Ferrari, Roberto
    Remme, Willem J.
    Simoons, Maarten L.
    Boersma, Eric
    Visseren, Frank L. J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 182 : 194 - 199
  • [40] Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study
    Ruge, Toralph
    Carlsson, Axel C.
    Kjoller, Erik
    Hilden, Jorgen
    Kolmos, Hans Jorn
    Sajadieh, Ahmad
    Kastrup, Jens
    Jensen, Gorm Boje
    Larsson, Anders
    Nowak, Christoph
    Jakobsen, Janus Christian
    Winkel, Per
    Gluud, Christian
    Arnlov, Johan
    ATHEROSCLEROSIS, 2019, 284 : 202 - 208